Full-Time

Key Account Director

Life Sciences

Posted on 6/13/2024

Tempus

Tempus

1,001-5,000 employees

Healthcare technology using AI for patient outcomes

No salary listed

Senior, Expert

Company Historically Provides H1B Sponsorship

Remote in USA + 1 more

More locations: Philadelphia, PA, USA

Job can be performed in Philadelphia, PA or remotely.

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Tempus referral from your network.

đź’ˇ

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Minimum 10+ years in Business Development and Sales in the Life Sciences sector as lead account and relationship manager (Pharma / Biotech)
  • Bachelor degree in a Science or Business discipline; Advanced degree (MBA, PhD or Healthcare certification) desired
Responsibilities
  • Develop and Drive global account strategy in coordination with our scientific and business operations teams
  • Meet and exceed revenue goals for All Tempus product lines at the account while delivering on established strategic objectives for specific client accounts
  • Build and maintain executive and R&D relationships & drive our CXO strategy leveraging Tempus senior leadership
  • Become an expert in the partner’s strategy, pipeline and portfolio to proactively determine all areas that the Tempus platform could be leveraged for advancing innovation
  • Negotiate, secure and manage pull-through of contracts with assigned client accounts
  • Align the cross functional team of Product Specialists, Alliance Managers, Translational Researchers and Commercial Operations to most efficiently identify and deliver value at our clients
  • Partner with our clients to develop and announce impactful case studies leveraging the Tempus platform to advance precision medicine
  • Contribute to the development of the Life Sciences portfolio by providing feedback to Leadership regarding client responses and suggestions; maintain a solution-oriented mindset
  • Track progress against defined strategic objectives and revenue goals; review progress/setbacks frequently with broader Account Team and Tempus Leadership
  • Travel approximately 40% of working time, domestically and internationally
  • Other duties as assigned

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide actionable insights, helping physicians make informed treatment decisions and identify gaps in patient care. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Unlike many competitors, Tempus combines extensive data analysis with a focus on precision medicine, aiming to improve healthcare delivery and drug development.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus' partnership with AstraZeneca and Pathos AI boosts oncology model development.
  • Acquisition of Deep 6 AI expands Tempus' network to 750 provider sites.
  • Projected 78% revenue growth by 2025 indicates strong market potential.

What critics are saying

  • Data privacy challenges arise from integrating Deep 6 AI's extensive network.
  • Partnership with AstraZeneca and Pathos AI may face data-sharing protocol issues.
  • Rapid expansion may strain Tempus' operational capabilities and affect service delivery.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids drug development by discovering novel targets and evaluating treatments.
  • Tempus' pan-cancer organoid platform enhances personalized therapeutic opportunities for cancer patients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↑ 0%
ETF Daily News
May 4th, 2025
NewEdge Advisors LLC Invests $49,000 in Tempus AI, Inc. (NASDAQ:TEM)

NewEdge Advisors LLC invests $49,000 in Tempus AI, Inc. (NASDAQ:TEM).

Tikr
May 1st, 2025
Is Tempus AI Stock Undervalued With 78% Revenue Growth Projected in 2025?

Valued at a market cap today of $9.2 billion, Tempus AI stock has surged around 47% since its initial public offering in June 2024.

Pharmaceutical Business Review
Apr 25th, 2025
Tempus AI, AstraZeneca, and Pathos AI join forces on cancer care

Tempus AI has entered into strategic partnerships with AstraZeneca and Pathos AI to develop a multimodal foundation model in oncology.

Fierce Biotech
Apr 23rd, 2025
Tempus AI in line for $200M from AstraZeneca, Pathos deal to develop cancer model

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ultimately be used to develop new cancer drugs.

Health Technology Insights
Apr 21st, 2025
Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S.

Tempus AI, Inc, a technology company leading the adoption of AI to advance precision medicine and patient care, announced the launch of the Tempus Advisory Board.

INACTIVE